Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Amazon Natural (AZNT) -- Ignore unavailable to you. Want to Upgrade?

To: bmart who wrote (4174)	9/7/1998 10:31:00 PM
From: Jeffrey S. Mitchell	Read Replies (1) \| Respond to of 26163

He felt that TON warranted an informal study and will be instructing his nursing staff on using TON as a sweetner and regulating it's use with his patients at Children's Memorial. Not if he wants to keep his license he won't. You just don't give patients a substance and say "hey, try this and let's see what happens". Get real. - Jeff

To: bmart who wrote (4174)	9/8/1998 9:10:00 AM
From: Hawkmoon	Respond to of 26163

Bmart, Which Children's Memorial Hospital might you be referring to?? Regards, Ron

To: bmart who wrote (4174)	9/8/1998 11:58:00 AM
From: tonto	Read Replies (1) \| Respond to of 26163

bmart, I received this response this morning: Dr. Jorge Daaboul tasted Touch of Nature yesterday at the request of a friend and commented that it tasted sweet. He has no professional opinion as to its potential as a sugar substitute. Mr. Mitchell, Tonight I met with Dr. Jorge Daaboul of Children's Memorial hospital. Dr. Daaboul is quite enthusiastic about the applications of TON with pediatric diabetic patients. The diabetic population at Children's Memorial is 625 patients. Dr. Daaboul felt that TON had a better taste than Aspartame while containing no phenylanaline. Aspartame is basically phenylanaline. Aspartame is contraindicated for use by pediatric diabetic patients because; * phenylanaline based neurotransmitters are prominent in the brain and CNS of growing children * aspartame has been associated with A.D.D. * decreased attention span Dr. Daaboul also cited TON's applications in celiac disease, where hi-fructose corn sweetners cause gaseousness in patients. Dr. Daabould cited that there are 2-3MM pediatric diabetic patients under the age of 15 in the U.S.. He felt that TON warranted an informal study and will be instructing his nursing staff on using TON as a sweetner and regulating it's use with his patients at Children's Memorial. Success there may lead to a formal study. RB Hopefully this will provide an accurate current position, "it tasted sweet, and he has no professional opinion regarding its potential."

To: bmart who wrote (4174)	9/16/1998 1:15:00 PM
From: Jeffrey S. Mitchell	Read Replies (3) \| Respond to of 26163

Mr. Mitchell, Tonight I met with Dr. Jorge Daaboul of Children's Memorial hospital. Dr. Daaboul is quite enthusiastic about the applications of TON with pediatric diabetic patients. Bmart, as I wrote to Riley G, all this RMIL thread stuff about you being the same person as Pugs is getting me quite confused, and I'm sure others as well. Could you please -- finally -- set the record straight on this? 1. Has Pugs (aka Gary Dobry) ever used your account from which to post messages on SI? 2. Is it just you or also Gary who has the relationship with Dr. Daaboul. If both of you do, was it you or Gary who gave Dr. Daaboul ToN to evaluate, and, if it was just you (as the above referenced post indicates), was Gary with you at the time? - Jeff